Crohn disease: A current perspective on genetics, autophagy and immunity

 Abstract

Crohn disease (CD) is a chronic and debilitating inflammatory condition of the gastrointestinal tract.1 Prevalence in western populations is 100–150/100,000 and somewhat higher in Ashkenazi Jews. Peak incidence is in early adult life, although any age can be affected and a majority of affected individuals progress to relapsing and chronic disease. Medical treatments rely significantly on empirical corticosteroid therapy and immunosuppression, and intestinal resectional surgery is frequently required. Thus, 80% of patients with CD come to surgery for refractory disease or complications. It is hoped that an improved understanding of pathogenic mechanisms, for example by studying the genetic basis of CD and other forms of inflammatory bowel diseases (IBD), will lead to improved therapies and possibly preventative strategies in individuals identified as being at risk.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
355 - 374
doi
10.4161/auto.7.4.13074
Type
Review
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Crohn disease: A current perspective on genetics, autophagy and immunity